TORONTO, March 22, 2011 (GLOBE NEWSWIRE) -- Kyto Biopharma Inc. (Pink Sheets:KBPH) ("Kyto") is a Florida-based development stage biopharmaceutical company focused on developing receptor medicated...
Kyto Biopharma Inc. (OTCBB: KBPH), is a Florida biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary...
Kyto Biopharma Inc. (“Kyto”), (OTCBB: KBPH), is pleased to announce that it has signed a licensing agreement with the Research Foundation of the State University of New York...
Kyto Biopharma Inc. (OTCBB: KBPH), is a biotechnology company focused on developing monoclonal antibody and oligonucleotide targeting therapeutics based on a proprietary vitamin...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | CS |
26 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | CS |
52 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | CS |
156 | -1 | -50 | 2 | 2 | 1 | 48 | 1.58785942 | CS |
260 | -1.05 | -51.2195121951 | 2.05 | 14.95 | 1 | 109 | 1.96070261 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約